The European Commission said on Friday it had given conditional approval for the use of COVID-19 antiviral remdesivir following an accelerated review process, Reuters reported.
The EU executive said the drug, produced by Gilead Sciences Inc, was the first medicine authorised in the European Union for treating COVID-19 following a “rolling review” begun by the European Medicines Agency at the e...